Spark Therapeutics buy Quitte
Start price
12.12.17
/
50%
€41.29
Target price
01.02.18
€50.51
Performance (%)
22.74%
End price
01.02.18
€50.68
Summary
This prediction ended on 01.02.18 with a price of €50.68. The prediction had a final performance of 22.74%. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Spark Therapeutics | - | - | - | - |
iShares Core DAX® | 1.851% | 5.158% | 17.711% | 19.954% |
iShares Nasdaq 100 | 1.573% | 2.589% | 39.053% | 56.636% |
iShares Nikkei 225® | -0.412% | -2.857% | 13.501% | 7.721% |
iShares S&P 500 | 1.128% | 2.485% | 29.871% | 47.507% |
Comments by Quitte for this prediction
In the thread Spark Therapeutics diskutieren
Lux am Ende des Tunnels
Luxturna hat den Priority Review-Status
der 12. Januar dürfte entscheidend sein
ich denke, es gibt Licht am Ende des Tunnels
(Zielkurs erreicht)